Hot Life Science Investor Mandate 3: Venture Capital Fund Seeking Early Stage Diagnostics and 510k Devices

24 Jul

A venture capital firm based in the Mid-Western United States is looking to make equity investments into early stage companies ranging from $250,000 – $2.5 million. The firm is actively reviewing opportunities throughout the United States with a preference for companies located in the Mid-West.

The firm is looking for companies in sectors of Medical Devices, Diagnostics and Healthcare IT. In the device space, the firm is looking for companies with 510k regulatory pathways and is not interested in companies requiring PMA’s or therapeutic companies. The firm is open to all technologies types and indications within those areas. The firm looks to get involved in early stages of company formation. The firm’s current portfolio includes life science companies working with Genomic testing and in-vivo robotic surgical devices.

The firm is looking for privately held companies with experienced management teams. The firm looks to take a board seat following investment and is open to working with companies in filling and building out management teams.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: